Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

NCT06252675 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

BIOLOGICAL: Obinutuzumab
BIOLOGICAL: Glofitamab
DRUG: Pirtobrutinib
PROCEDURE: Tumor Imaging
PROCEDURE: Biospecimen Collection
DEVICE: ClonoSeq Assay
PROCEDURE: Bone Marrow Biopsy

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]
[object Object]